Lauren Scott, MD
Assistant Professor
Boston University School of Medicine
Dept of Family Medicine

MD, Boston University School of Medicine
PhD, University of British Columbia
favorite icon LinkedIn

Lauren Scott, MD, PhD is an Assistant Professor of Family Medicine at the Boston University School of Medicine and a Physician in the Department of Family Medicine at South End Community Health Center. In 2016, Dr. Scott won the Resident Leadership Award from her alma mater McMaster University where she was previously the Chief Resident in 2014. She is licensed in both Ontario and Massachusetts and was a member of both the Canadian and American Medical Association.

2016 McMaster University: Resident Leadership Award
2013 Alpha Omega Alpha
2012 Boston University: Tom Gilbert Family Medicine Award
2011 Boston University: Dr. Lois Rogers Scholarship for Women in Family Medicine
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Temple JR, Choi HJ, Reuter T, Wolfe D, Taylor CA, Madigan S, Scott LE. Childhood Corporal Punishment and Future Perpetration of Physical Dating Violence. J Pediatr. 2018 Mar; 194:233-237. PMID: 29217100.
  2. Telpoukhovskaia MA, Rodríguez-Rodríguez C, Cawthray JF, Scott LE, Page BD, Alí-Torres J, Sodupe M, Bailey GA, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. Metallomics. 2014 Feb; 6(2):249-62. PMID: 23999879.
  3. Telpoukhovskaia MA, Rodríguez-Rodríguez C, Scott LE, Page BD, Patrick BO, Orvig C. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones. J Inorg Biochem. 2014 Mar; 132:59-66. PMID: 24393377.
  4. Scott LE, Telpoukhovskaia M, Rodríguez-Rodríguez C, Merkel M, Bowen ML, Page BDG, Green DE, Storr T, Thomas F, Allen DD, Lockman PR, Patrick BO, Adam MJ, Orvig C. N-Aryl-substituted 3-(ß-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy. Chemical Science. 2011; 2:642-8.
  5. Green DE, Bowen ML, Scott LE, Storr T, Merkel M, Böhmerle K, Thompson KH, Patrick BO, Schugar HJ, Orvig C. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Trans. 2010 Feb 14; 39(6):1604-15. PMID: 20104324.
  6. Scott LE, Orvig C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev. 2009 Oct; 109(10):4885-910. PMID: 19637926.
  7. Storr T, Scott LE, Bowen ML, Green DE, Thompson KH, Schugar HJ, Orvig C. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. Dalton Trans. 2009 Apr 28; (16):3034-43. PMID: 19352532.
  8. Scott LE, Page BD, Patrick BO, Orvig C. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Trans. 2008 Dec 07; (45):6364-7. PMID: 19002321.
  9. Storr T, Merkel M, Song-Zhao GX, Scott LE, Green DE, Bowen ML, Thompson KH, Patrick BO, Schugar HJ, Orvig C. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc. 2007 Jun 13; 129(23):7453-63. PMID: 17511455.
  10. Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Böhmerle K, Thomas F, Allen DD, Lockman PR, Merkel M, Thompson KH, Orvig C. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed Engl. 2007; 46(10):1716-8. PMID: 17397084.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 3 publications in 2009

Contact for Mentoring:

771 Albany Street
Boston MA 02118
Google Map

Scott's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department